Company intelligence / Profile preview

Healix

Ownership: Private
Development stage: Commercial

Overview

Healix operates one of the largest networks of ambulatory infusion centers in the United States and provides accredited specialty pharmacy services. The company partners with physicians to deliver patient-focused outpatient infusion care and supports clinical outcomes research through its real-world data access. It also offers pharmaceutical distribution solutions and patient support/hub services.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Injectable drugs (various classes)Infusion therapies (various modalities, including biologics, monoclonal antibodies, small molecules)
Industry: Non-Academic Healthcare

Partnerships

Physician practicesHospitalsHealth systemsPharmaceutical manufacturers

Beyond the preview

Go deeper on Healix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Healix.

Explore the full profile